Menstrual cycle markers of ovarian aging and sex steroid hormone genotypes.
We related variation in 4 sex steroid genes to 3 phenotypic indicators of ovarian aging, including no evidence of luteal activity as a marker of anovulatory cycles, shorter or longer menstrual cycle lengths, and the profiles of metabolites of estrogens, progesterone, follicle-stimulating hormone, and luteinizing hormone measured in urine samples collected daily across a menstrual cycle in women aged 43 to 53 years. The study sample included 485 menstruating women without hormone therapy who had collected daily urine hormone samples across 1 menstrual cycle or 50 days, whichever occurred first. There were 14 single nucleotide polymorphisms from 4 genes, including estrogen receptor-alpha (ESR1), estrogen receptor-beta, aromatase, and 17beta hydroxysteroid dehydrogenase type 1, related to ovarian aging phenotypes that include the presence or absence of luteal activity, menstrual cycle lengths < or > 24 to 31 days, and profiles of urinary hormone metabolites. Women with the TT genotype of ESR1 rs3798577 have evidence of advanced ovarian aging compared with women with the CT or CC genotypes, after adjustment for race/ethnicity, chronologic age, and race/ethnicity-specific body mass index. Further, women with the TC and CC genotypes of ESR1 rs2234693 may have a greater likelihood of more advanced ovarian aging than do women with the TT genotype, adjusting for covariates. Using a candidate gene approach, 2 ESR1 polymorphisms are related to 3 phenotypic markers of ovarian aging, suggesting a possible role for the ESR1 gene in the timing of the menopausal transition.
Sowers
MaryFran R
MR
Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan 48104, USA. mfsowers@umich.edu
Jannausch
Mary L
ML
McConnell
Daniel S
DS
Kardia
Sharon R
SR
Randolph
John F
JF
D015067:17-Hydroxysteroid Dehydrogenases / Q000235:genetics; D000328:Adult; D000375:Aging / Q000235:genetics / Q000502:physiology*; D001141:Aromatase / Q000235:genetics; D015415:Biomarkers / Q000032:analysis; D003338:Corpus Luteum / Q000378:metabolism; D047628:Estrogen Receptor alpha / Q000235:genetics; D047629:Estrogen Receptor beta / Q000235:genetics; D004967:Estrogens / Q000378:metabolism / Q000652:urine; D005260:Female; D005640:Follicle Stimulating Hormone / Q000378:metabolism / Q000652:urine; D005838:Genotype; D012739:Gonadal Steroid Hormones / Q000378:metabolism*; D006801:Humans; D007986:Luteinizing Hormone / Q000378:metabolism / Q000652:urine; D008597:Menstrual Cycle / Q000235:genetics* / Q000378:metabolism; D008875:Middle Aged; D010053:Ovary / Q000502:physiology*; D020641:Polymorphism, Single Nucleotide; D011374:Progesterone / Q000378:metabolism / Q000652:urine; D044469:Racial Groups
D015415:Biomarkers; D047628:Estrogen Receptor alpha; D047629:Estrogen Receptor beta; D004967:Estrogens; D012739:Gonadal Steroid Hormones; D011374:Progesterone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D015067:17-Hydroxysteroid Dehydrogenases; D001141:Aromatase